STOK - SunTrust sees 16% upside in Amgen in premarket analyst action November, 12 2019 09:12 AM Stoke Therapeutics Inc. Alexion Pharmaceuticals (NASDAQ:ALXN) initiated with Buy rating and $125 (15% upside) price target at SunTrust.More news on: Alexion Pharmaceuticals, Inc., Amgen Inc., Arcus Biosciences, Inc., Healthcare stocks news, Stocks on the move, , Read more ...